Tensall Bio-Tech Co. Ltd. said its normalized net income for the first half came to 30 Taiwan cents per share, an increase from 2 cents per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was NT$9.2 million, a gain from NT$532,500 in the prior-year period.

Total revenue rose 20.7% on an annual basis to NT$99.4 million from NT$82.4 million, and total operating expenses climbed 5.5% on an annual basis to NT$84.0 million from NT$79.6 million.

Reported net income rose year over year to NT$14.7 million, or 48 cents per share, from NT$581,000, or 2 cents per share.

As of Aug. 15, US$1 was equivalent to NT$31.33.